All Cases

Portfolio and Early Stage

Assessment of a novel Ophthalmology research platform to prioritize investment in potential pipeline indications

Portfolio assessment for a leading, clinical-stage Ophthalmology Biotech to understand portfolio planning implications of a dynamic marketplace

Lifecycle management and portfolio planning in pain-related diseases to prioritize time/resource and investment

Therapeutic landscape characterization for a CNS-targeted Enzyme replacement therapy, laying the groundwork for future clinical activities

Business model design with critical investment milestones that inform investment decisions for a clinical stage biotech with CNS Gene Delivery Platform and large portfolio of drugs